Cargando…
DNA Repair and Signaling in Immune-Related Cancer Therapy
Cancer therapy using immune checkpoint inhibitors (ICIs) is a promising clinical strategy for patients with multiple types of cancer. The expression of programmed cell death ligand-1 (PD-L1), an immune-suppressor ligand, in cancer cells is a factor that influences the efficacy of ICI therapy, partic...
Autores principales: | Kakoti, Sangeeta, Sato, Hiro, Laskar, Siddhartha, Yasuhara, Takaaki, Shibata, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506057/ https://www.ncbi.nlm.nih.gov/pubmed/33102516 http://dx.doi.org/10.3389/fmolb.2020.00205 |
Ejemplares similares
-
p53 deficiency augments nucleolar instability after ionizing irradiation
por: Kakoti, Sangeeta, et al.
Publicado: (2019) -
DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells
por: Sato, Hiro, et al.
Publicado: (2017) -
Editorial: Cancer Therapeutics: Targeting DNA Repair Pathways
por: Suraweera, Amila, et al.
Publicado: (2022) -
Editorial: The repair of DNA–protein crosslinks
por: Sun, Yilun, et al.
Publicado: (2023) -
Computational Study on DNA Repair: The Roles of Electrostatic Interactions Between Uracil-DNA Glycosylase (UDG) and DNA
por: Xie, Yixin, et al.
Publicado: (2021)